tradingkey.logo

Breathe BioMedical Ord Shs (Proposed)

BRTH
0.000
Close 12/19, 16:00ETQuotes delayed by 15 min
--Market Cap
--P/E TTM
You can access the annual and quarterly cash flow statements of Breathe BioMedical Ord Shs (Proposed) to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024Q1
FY2023Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
---1.15M
---507.29K
Net income from continuing operations
---2.42M
---1.16M
Operating gains losses
--96.52K
--92.79K
Change in working capital
--834.87K
--454.97K
-Change in receivables
---201.81K
--707.46K
-Change in prepaid expenses
---36.83K
---23.73K
Cash from non-recurring investing activities
Cash from operating activities
---1.15M
---507.29K
Investing cash flow
Net cash from continuing investing activities
--512.49K
--23.84K
Capital expenditures
--512.49K
--23.84K
Net cash flow from disposal of fixed assets
--512.49K
--23.84K
Cash from non-current investing activities
Net cash flow from investing activities
---512.49K
---23.84K
Financing cash flow
Cash flow from continuous financing activities
--2.30M
--200.00K
Net cash flow from debt Issuance/repayment
--1.62M
--200.00K
Net cash flow from common stock issuance/repurchase
--599.51K
----
Proceeds from stock option exercised by employees
--77.52K
----
Net cash from non-recurrent financing activities
Net cash from financing activities
--2.30M
--200.00K
Net cash flow
Beginning cash balance
--1.19M
----
Current period cash flow changes
--632.83K
---331.12K
Ending cash balance
--1.82M
----
Free cash flow
---1.67M
---531.12K
Currency unit
USD
USD
Audit opinions
--
--

FAQs

What is the cash flow statement?

This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.
KeyAI